PYRIMIDINE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE

The present invention describes pyrimidine compounds of Formula I that are useful as anaplastic lymphoma kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.

Saved in:
Bibliographic Details
Main Authors LEWIS, RICHARD, T, CHENG, ALAN, C, WHITTINGTON, DOUGLAS, A, BRYAN, MARIAN, C, DOHERTY, ELIZABETH, M, FALSEY, JAMES, R, FELLOWS, INGRID, M, KIM, JOSEPH, L, POTASHMAN, MICHELE, H
Format Patent
LanguageEnglish
French
German
Published 04.03.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention describes pyrimidine compounds of Formula I that are useful as anaplastic lymphoma kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
Bibliography:Application Number: EP20110781042